Phase II Open-label Single Arm Study of Oxaliplatin Combined With Cisplatin and 5FU in Advanced Esophagus Cancer Patients.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Cisplatin; Fluorouracil; Oxaliplatin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 21 Oct 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 21 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Apr 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.